Cargando…

Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1(+) triple negative breast cancer cells

Immune check point inhibitors targeting programmed cell death protein-1 (PD-1) and its ligand (PD-L1) have shown clinical success in treatment of human malignancies. Triple negative breast cancer (TNBC), which is primarily characterized by high heterogeneity and presence of tumor infiltrating lympho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohan, Nishant, Hosain, Salman, Zhao, Jun, Shen, Yi, Luo, Xiao, Jiang, Jiangsong, Endo, Yukinori, Wu, Wen Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685513/ https://www.ncbi.nlm.nih.gov/pubmed/31428520 http://dx.doi.org/10.1080/2162402X.2019.1624128

Ejemplares similares

Payload of T-DM1 binds to cell surface cytoskeleton-associated protein 5 to mediate cytotoxicity of hepatocytes
por: Endo, Yukinori, et al.
Publicado: (2018)

Prognostic role of proliferating CD8(+) cytotoxic Tcells in human cancers
por: Blessin, Niclas C., et al.
Publicado: (2021)

TcellSubC: An Atlas of the Subcellular Proteome of Human T Cells
por: Joshi, Rubin Narayan, et al.
Publicado: (2019)

Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity
por: Jiang, Jiangsong, et al.
Publicado: (2017)

FAK-Dependent Cell Motility and Cell Elongation
por: Katoh, Kazuo
Publicado: (2020)

DES-Tcell is a knowledgebase for exploring immunology-related literature
por: AlSaieedi, Ahdab, et al.
Publicado: (2021)

Differential regulation of cell motility and invasion by FAK
por: Hsia, Datsun A., et al.
Publicado: (2003)

Beta-catenin Forms Protein Aggregation at High Concentrations in HEK293TCells
por: Jazi, Marie Saghaeian, et al.
Publicado: (2017)

Author Correction: DES-Tcell is a knowledgebase for exploring immunology-related literature
por: AlSaieedi, Ahdab, et al.
Publicado: (2021)

Bronchial fibroblasts modulate CD4+Tcells phenotype towards Th17 in asthma
por: Loubaki, Lionel, et al.
Publicado: (2010)

Atezolizumab Induces Necroptosis and Contributes to Hepatotoxicity of Human Hepatocytes
por: Endo, Yukinori, et al.
Publicado: (2023)

Shc and Fak Differentially Regulate Cell Motility and Directionality Modulated by Pten
por: Gu, Jianguo, et al.
Publicado: (1999)

FAK promotes recruitment of talin to nascent adhesions to control cell motility
por: Lawson, Christine, et al.
Publicado: (2012)

FAK promotes recruitment of talin to nascent adhesions to control cell motility
por: Lawson, Christine, et al.
Publicado: (2012)

Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer
por: Pan, Mei-Ren, et al.
Publicado: (2019)

TcellInflamedDetector: an R package to distinguish T cell inflamed tumor types from non–T cell inflamed tumor types
por: Yang, San-Duk, et al.
Publicado: (2022)

Tyrosine phosphorylation of cortactin by the FAK-Src complex at focal adhesions regulates cell motility
por: Wang, Wenqi, et al.
Publicado: (2011)

Cell proliferation and invasion are regulated differently by EGFR and MRP1 in T-DM1-resistant breast cancer cells
por: Endo, Yukinori, et al.
Publicado: (2019)

PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer
por: Rugo, Hope S, et al.
Publicado: (2021)

Coordination of glioblastoma cell motility by PKCι
por: Baldwin, R Mitchell, et al.
Publicado: (2010)

New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab
por: Seetharamu, Nagashree, et al.
Publicado: (2017)

Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis
por: Voudouri, Kallirroi, et al.
Publicado: (2016)

Th40 cells (CD4(+)CD40(+) Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells
por: Vaitaitis, Gisela M., et al.
Publicado: (2017)

Cost-effectiveness analysis of atezolizumab in advanced triple-negative breast cancer
por: Phua, Lee Cheng, et al.
Publicado: (2020)

Case Report: A Case Study Documenting the Activity of Atezolizumab in a PD-L1-Negative Triple-Negative Breast Cancer
por: Brasó-Maristany, Fara, et al.
Publicado: (2021)

Evaluation of Tcell exhaustion based on the expression of EOMES, Tbet and co-inhibitory receptors in severe and non-severe covid-19 patients
por: Saeedifar, Amir Mohammad, et al.
Publicado: (2023)

Vinculin modulation of paxillin–FAK interactions regulates ERK to control survival and motility
por: Subauste, M. Cecilia, et al.
Publicado: (2004)

Structural basis of the therapeutic anti-PD-L1 antibody atezolizumab
por: Zhang, Fei, et al.
Publicado: (2017)

Enteric glial hub cells coordinate intestinal motility
por: Scavuzzo, Marissa A., et al.
Publicado: (2023)

PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer
por: Saleh, Reem, et al.
Publicado: (2019)

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
por: Kowanetz, Marcin, et al.
Publicado: (2018)

Tetraspanin 7 promotes osteosarcoma cell invasion and metastasis by inducing EMT and activating the FAK-Src-Ras-ERK1/2 signaling pathway
por: Shao, Shijie, et al.
Publicado: (2022)

Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer
por: Fabi, Alessandra, et al.
Publicado: (2023)

Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
por: Lee, Hyun Tae, et al.
Publicado: (2017)

Tyrosine Phosphatases in the HER2-Directed Motility of Ovarian Cancer Cells: Involvement of PTPN12, ERK5 and FAK
por: Villa-Moruzzi, Emma
Publicado: (2011)

Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis
por: Hammer, Alan, et al.
Publicado: (2016)

Involvement of FAK-ERK2 signaling pathway in CKAP2-induced proliferation and motility in cervical carcinoma cell lines
por: Guo, Qi-sang, et al.
Publicado: (2017)

A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action
por: Mohan, Nishant, et al.
Publicado: (2021)

Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2019)

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma
por: Giovannini, Catia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mjjj73eo4jv0es70k6om727plh